Efalex Brain Formula was trailblazing in understanding the role and importance of DHA and other Omega 3 & 6 fats on children’s brain health. Efalex was the first supplement of its kind to undergo scientific vigour when it was launched in 1986, since then Efamol have continued to research its beneficial effects. Efalex’s unique formula contains Omega 3 fatty acids DHA and AA and Omega 6 GLA from Efamol’s unique Evening Primrose Oil.
Brain DHA levels increase throughout childhood and adolescence, developing faster than any other stage in life. New connections between brain and nerve cells are being made constantly in response to these new environments and experiences. This constant change of brain networks helps with the development of visual, attentional, and motor skills, cognition, and language.
Participants showed significant improvements on all subscales of the Social Responsiveness Scale (P<0.01) and the Social and Attention Problems syndrome scales of the Child Behaviour Checklist (P<0.05). Blood fatty acid levels were significantly correlated with changes in the core symptoms of ASD.
20 of the 30 autistic children had clinically significant improvements in autistic behaviours (CARS)- improved concentration, eye contact, language development and motor skills. Blood DHA and AA increased with treatment from sub-normal levels
After treatment with Efalex there were significant improvements in ADHD symptoms including a 73% reduction in hyperactivity, 64% improvement in attention, 69% improvement in conduct and a 79% improvement in opposition defiant disorder.
The Beechlawn Study was the first double-blind, placebo controlled trial to be published in a peer reviewed journal. It showed Efalex could reduce a number of ADHD related symptoms including cognitive problems, anxiety and hyperactivity. After 12 weeks mean scores for cognitive problems and general behaviour problems were significantly lower for the group treated with HUFA than for the placebo group
